Manremyc, a spin-off of the IGTP specialised in the development of a probiotic against tuberculosis, has opened a funding round through Capital Cell, the first on-line investment platform in Europe specialized in biomedicine. The objective of the campaign is to reach 250,000 euros, with a minimum investment requirement per person of only 600 euros. Up to now, the company has secured 35% of the investment, which includes participation from the Reig family, main shareholders in the pharmaceutical company Reig Jofre.
At the IGTP TODAY
The Program for Predictive and Personalized Medicine of Cancer (PMPPC) was an initiative of Manuel Perucho and Manel Puig and resulted from the reorganization of the Can Ruti Campus research structure promoted by the Catalan Government in 2014. Dr. Perucho directed the program until March 2019.
Mireia Belmonte the Olympic swimming medallist from Badalona visited the Germans Trias i Pujol Research Institute (IGTP) on Campus Can Ruti on Wednesday 29 May. The event marked the start of a collaboration in support of the Amics de Can Ruti (Friends of Can Ruti) to raise awareness of the importance of health research. During her visit, she presented a watch, which she helped to design, that will soon be available through the web and events organized by the Amics de Can Ruti. All proceeds from the sales of the watch will go to research projects on the campus.
The IGTP participates in the debates of the 11th Research Workshop of the ICS: childhood obesity and rare diseases
Experts in paediatric research agree on the need to anticipate and act on obesity from childhood. The importance of early interventions to prevent obesity and excess weight and research into rare diseases have been the main topics of the 11th Research Workshop of the Catalan Institute of Health (ICS), which took place at the Seminari de Tarragona (Centre Tarraconense).
The first series of Can Ruti Biomedical Research Seminars has been a great success. The seminars have been organized jointly by the Germans Trias i Pujol Research Institute, IrsiCaixa, AIDS Research Institute, and sponsored by AstraZeneca and Celgene.
Surgeons in the Germans Trias Hospital are awarded a Llavor grant to commercialize a new surgical device
The project Mechanical atraumatic microvascular sutures has been awarded a Llavor grant (Seed Grant) by the Catalan Agency for Management of University and Research Grants (AGAUR). This research project is led by Dr M Carmen Higueras Suñé, Head of the Plastic Surgery Service at the Germans Trias Hospital, and the scientist responsible for the commercial development of the device is Dr David Priego, a specialist surgeon in the same department in the hospital.
Ten international projects have been selected for the second edition of CRAASH Barcelona and Aniling is one of them. CRAASH is the business acceleration programme organized by Biocat and CIMIT (Boston). Aniling is a spin-off company of the IGTP, which has developed a method for analysing the genome and epigenome of a patient simultaneously, an advance in personalized medicine for both research and clinical settings.
The IGTP is a partner in an international project to improve personalized treatments for childhood cancer using artificial intelligence tools
This year the Childhood Liver Oncology Group (c-LOG) led by Carolina Armengol was one of 21 prestigious International partners from 11 countries joining in the Individualized Paediatric Cure (iPC) Project. The project has 15 million euros funding for four years and is led by IBM in Switzerland and Technikon in Austria.
Saint George's Day is one of the most important events on our calendar and this year the Friends of Can Ruti also want to celebrate it by joining in with the activities in the centre of our city of Badalona.
Researchers at the IGTP identify new candidate biomarkers for the initial stages of childhood diabetes type 1
The Immunology of Diabetes Group at the IGTP has published its first results for their new research line on diabetes type 1 (T1D) in children, focussed on the mechanisms of the re-establishment of tolerance in children at the start of the disease and the definition of new biomarkers for its remission.